Skip to main content
Erschienen in: Journal of Neurology 9/2012

01.09.2012 | Medical Progress in the Journal of Neurology

Rehabilitation interventions in multiple sclerosis: an overview

verfasst von: Serafin Beer, Fary Khan, Jürg Kesselring

Erschienen in: Journal of Neurology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Multiple sclerosis is a complex, heterogeneous disease associated with long-term disability. Despite the availability of advanced disease-modifying and symptomatic therapies that may decrease activity and progression of disease and alleviate complaints to a certain extent, there is still a need for comprehensive rehabilitation interventions in order to reduce sequels and symptoms of the disease on personal activities and social participation to achieve the highest possible independence and the best quality of life. Timing and setting of rehabilitation interventions should be selected individually depending on disease phase, functional deficits, personal requirements, as well as specific goals. In addition, limitations and disease-specific characteristics that may influence rehabilitation outcome should be noted. Rehabilitation interventions should be considered early for maintaining functional capacity and reducing risk for losing important abilities or independence. Due to gradual failure of adaptive compensatory mechanisms along the course of disease, benefits of rehabilitation interventions are generally higher in earlier phases of MS. Inpatient and outpatient multidisciplinary rehabilitation has been shown to be beneficial in improving disability, participation and quality of life despite progression of the disease. Good evidence exists for different specific interventions improving physical and cognitive performance. Other important issues responsible for beneficial effects of comprehensive rehabilitation in MS include education, instruction, and information of patients and caregivers. Comprehensive assessment of health domains in MS patients using standardized framework and common language for describing the impact of disease at different levels, using International Classification of Functioning, Disability and Health (ICF) core sets may increase the knowledge of needs of these patients for more efficient and adapted rehabilitation interventions meeting these individual requirements, and promote perception and acceptance of rehabilitation as a valuable treatment option in MS. ICF core sets may increase the knowledge of more efficient and adapted rehabilitation measures meeting more properly individual requirements, and promote perception and acceptance of rehabilitation as a valuable treatment option in MS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520–532PubMedCrossRef Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520–532PubMedCrossRef
2.
Zurück zum Zitat Alonso A, Hernan MA (2008) Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71:129–135PubMedCrossRef Alonso A, Hernan MA (2008) Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71:129–135PubMedCrossRef
3.
Zurück zum Zitat Bentzen J, Flachs EM, Stenager E, Bronnum-Hansen H, Koch-Henriksen N (2010) Prevalence of multiple sclerosis in Denmark 1950–2005. Mult Scler 16:520–525PubMedCrossRef Bentzen J, Flachs EM, Stenager E, Bronnum-Hansen H, Koch-Henriksen N (2010) Prevalence of multiple sclerosis in Denmark 1950–2005. Mult Scler 16:520–525PubMedCrossRef
4.
Zurück zum Zitat Chitnis T, Glanz B, Jaffin S, Healy B (2009) Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 15:627–631PubMedCrossRef Chitnis T, Glanz B, Jaffin S, Healy B (2009) Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 15:627–631PubMedCrossRef
5.
6.
Zurück zum Zitat Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210–218PubMedCrossRef Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210–218PubMedCrossRef
7.
Zurück zum Zitat Koutsis G, Evangelopoulos ME, Andreadou E, Mandellos D, Karachalios G, Potagas C, Karantoni E, Karouli M, Chrysovitsanou C, Vassilopoulos D, Sfagos C (2010) The onset of multiple sclerosis in Greece: a single-center study of 1,034 consecutive patients. Eur Neurol 63:350–356PubMedCrossRef Koutsis G, Evangelopoulos ME, Andreadou E, Mandellos D, Karachalios G, Potagas C, Karantoni E, Karouli M, Chrysovitsanou C, Vassilopoulos D, Sfagos C (2010) The onset of multiple sclerosis in Greece: a single-center study of 1,034 consecutive patients. Eur Neurol 63:350–356PubMedCrossRef
8.
Zurück zum Zitat Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M (2007) Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 6:887–902PubMedCrossRef Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M (2007) Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 6:887–902PubMedCrossRef
9.
Zurück zum Zitat Martinelli V, Rodegher M, Moiola L, Comi G (2004) Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis. Neurol Sci 25(Suppl 4):S350–S355PubMedCrossRef Martinelli V, Rodegher M, Moiola L, Comi G (2004) Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis. Neurol Sci 25(Suppl 4):S350–S355PubMedCrossRef
10.
11.
Zurück zum Zitat Kesselring J, Beer S (2005) Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 4:643–652PubMedCrossRef Kesselring J, Beer S (2005) Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 4:643–652PubMedCrossRef
12.
Zurück zum Zitat Pfleger CC, Flachs EM, Koch-Henriksen N (2010) Social consequences of multiple sclerosis (1): early pension and temporary unemployment–a historical prospective cohort study. Mult Scler 16:121–126PubMedCrossRef Pfleger CC, Flachs EM, Koch-Henriksen N (2010) Social consequences of multiple sclerosis (1): early pension and temporary unemployment–a historical prospective cohort study. Mult Scler 16:121–126PubMedCrossRef
13.
Zurück zum Zitat Pfleger CC, Flachs EM, Koch-Henriksen N (2010) Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Mult Scler 16:878–882PubMedCrossRef Pfleger CC, Flachs EM, Koch-Henriksen N (2010) Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Mult Scler 16:878–882PubMedCrossRef
14.
Zurück zum Zitat Kesselring J (2010) Disease progression in multiple sclerosis. I. Impaired mobility and its impact on limitations of activities and social participation. Eur Neurol Rev 5:56–60 Kesselring J (2010) Disease progression in multiple sclerosis. I. Impaired mobility and its impact on limitations of activities and social participation. Eur Neurol Rev 5:56–60
15.
Zurück zum Zitat Kobelt G, Berg J, Atherly D, Hadjimichael O (2006) Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology 66:1696–1702PubMedCrossRef Kobelt G, Berg J, Atherly D, Hadjimichael O (2006) Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology 66:1696–1702PubMedCrossRef
16.
Zurück zum Zitat Kobelt G, Berg J, Lindgren P, Fredrikson S, Jonsson B (2006) Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 77:918–926PubMedCrossRef Kobelt G, Berg J, Lindgren P, Fredrikson S, Jonsson B (2006) Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 77:918–926PubMedCrossRef
17.
Zurück zum Zitat Patwardhan MB, Matchar DB, Samsa GP, McCrory DC, Williams RG, Li TT (2005) Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler 11:232–239PubMedCrossRef Patwardhan MB, Matchar DB, Samsa GP, McCrory DC, Williams RG, Li TT (2005) Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler 11:232–239PubMedCrossRef
18.
Zurück zum Zitat Compston DAS, Milligan NM, Hughes PJ, Gibbs J, McBroom V, Morgan BP, Campbell AK (1987) A double-blind controlled trial of high-dose methylprednisolone in patients with multiple sclerosis: 2. laboratory results. J Neurol Neurosurg Psychiatry 50:517–522PubMedCrossRef Compston DAS, Milligan NM, Hughes PJ, Gibbs J, McBroom V, Morgan BP, Campbell AK (1987) A double-blind controlled trial of high-dose methylprednisolone in patients with multiple sclerosis: 2. laboratory results. J Neurol Neurosurg Psychiatry 50:517–522PubMedCrossRef
19.
Zurück zum Zitat Milligan NM, Newcombe R, Compston DAS (1987) A double-blind controlled trial of high-dose methylprednisolone in patients with multiple sclerosis: 1. clinical effects. J Neurol Neurosurg Psychiatry 50:511–516PubMedCrossRef Milligan NM, Newcombe R, Compston DAS (1987) A double-blind controlled trial of high-dose methylprednisolone in patients with multiple sclerosis: 1. clinical effects. J Neurol Neurosurg Psychiatry 50:511–516PubMedCrossRef
20.
Zurück zum Zitat Sloka JS, Stefanelli M (2005) The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler 11:425–432PubMedCrossRef Sloka JS, Stefanelli M (2005) The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler 11:425–432PubMedCrossRef
21.
Zurück zum Zitat Wingerchuk DM (2008) Current evidence and therapeutic strategies for multiple sclerosis. Semin Neurol 28:56–68PubMedCrossRef Wingerchuk DM (2008) Current evidence and therapeutic strategies for multiple sclerosis. Semin Neurol 28:56–68PubMedCrossRef
22.
Zurück zum Zitat Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Radu EW, Metzig C, Bauer L, Lanius V, Sandbrink R, Pohl C (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8:987–997PubMedCrossRef Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Radu EW, Metzig C, Bauer L, Lanius V, Sandbrink R, Pohl C (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8:987–997PubMedCrossRef
23.
Zurück zum Zitat Bates D (2011) Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials. Neurology 76:S14–S25PubMedCrossRef Bates D (2011) Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials. Neurology 76:S14–S25PubMedCrossRef
24.
Zurück zum Zitat Rieckmann P, Traboulsee A, Devonshire V, Oger J (2008) Escalating immunotherapy of multiple sclerosis. Ther Adv Neurol Disord 1:181–192PubMedCrossRef Rieckmann P, Traboulsee A, Devonshire V, Oger J (2008) Escalating immunotherapy of multiple sclerosis. Ther Adv Neurol Disord 1:181–192PubMedCrossRef
25.
Zurück zum Zitat Kappos L, Radue EW, O’Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. New Engl J Med 362:387–401PubMedCrossRef Kappos L, Radue EW, O’Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. New Engl J Med 362:387–401PubMedCrossRef
26.
Zurück zum Zitat Freedman MS (2011) Long-term follow-up of clinical trials of multiple sclerosis therapies. Neurology 76:26–34CrossRef Freedman MS (2011) Long-term follow-up of clinical trials of multiple sclerosis therapies. Neurology 76:26–34CrossRef
27.
Zurück zum Zitat Havrdova E, Galetta S, Hutchinson M, Stefoski D, Bates D, Polman CH, O’Connor PW, Giovannoni G, Phillips JT, Lublin FD, Pace A, Kim R, Hyde R (2009) Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the natalizumab safety and efficacy in relapsing-remitting multiple sclerosis (AFFIRM) study. Lancet Neurol 8:254–260PubMedCrossRef Havrdova E, Galetta S, Hutchinson M, Stefoski D, Bates D, Polman CH, O’Connor PW, Giovannoni G, Phillips JT, Lublin FD, Pace A, Kim R, Hyde R (2009) Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the natalizumab safety and efficacy in relapsing-remitting multiple sclerosis (AFFIRM) study. Lancet Neurol 8:254–260PubMedCrossRef
28.
Zurück zum Zitat Bar-Or A, Rieckmann P, Traboulsee A, Yong VW (2011) Targeting progressive neuroaxonal injury: lessons from multiple sclerosis. CNS Drugs 25:783–799PubMedCrossRef Bar-Or A, Rieckmann P, Traboulsee A, Yong VW (2011) Targeting progressive neuroaxonal injury: lessons from multiple sclerosis. CNS Drugs 25:783–799PubMedCrossRef
29.
Zurück zum Zitat Paltamaa J, Sarasoja T, Wikstrom J, Malkia E (2006) Physical functioning in multiple sclerosis: a population-based study in central Finland. J Rehabil Med 38:339–345PubMedCrossRef Paltamaa J, Sarasoja T, Wikstrom J, Malkia E (2006) Physical functioning in multiple sclerosis: a population-based study in central Finland. J Rehabil Med 38:339–345PubMedCrossRef
30.
Zurück zum Zitat Thompson AJ, Toosy AT, Ciccarelli O (2010) Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 9:1182–1199PubMedCrossRef Thompson AJ, Toosy AT, Ciccarelli O (2010) Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 9:1182–1199PubMedCrossRef
31.
Zurück zum Zitat Erwin A, Gudesblatt M, Bethoux F, Bennett SE, Koelbel S, Plunkett R, Sadiq S, Stevenson VL, Thomas AM, Tornatore C, Zaffaroni M, Hughes M (2011) Intrathecal baclofen in multiple sclerosis: too little, too late? Mult Scler 17:623–629PubMedCrossRef Erwin A, Gudesblatt M, Bethoux F, Bennett SE, Koelbel S, Plunkett R, Sadiq S, Stevenson VL, Thomas AM, Tornatore C, Zaffaroni M, Hughes M (2011) Intrathecal baclofen in multiple sclerosis: too little, too late? Mult Scler 17:623–629PubMedCrossRef
32.
Zurück zum Zitat Stetkarova I, Yablon SA, Kofler M, Stokic DS (2010) Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair 24:609–619PubMedCrossRef Stetkarova I, Yablon SA, Kofler M, Stokic DS (2010) Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair 24:609–619PubMedCrossRef
33.
Zurück zum Zitat Hyman N, Barnes M, Bhakta B, Cozens A, Bakheit M, Kreczy-Kleedorfer B et al (2000) Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double-blind, placebo-controlled, dose-ranging study. J Neurol Neurosurg Psychiatry 68:707–712PubMedCrossRef Hyman N, Barnes M, Bhakta B, Cozens A, Bakheit M, Kreczy-Kleedorfer B et al (2000) Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double-blind, placebo-controlled, dose-ranging study. J Neurol Neurosurg Psychiatry 68:707–712PubMedCrossRef
34.
Zurück zum Zitat Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C (2004) Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci 218:103–108PubMedCrossRef Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C (2004) Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci 218:103–108PubMedCrossRef
35.
Zurück zum Zitat Barnes MP (2006) Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother 7:607–615PubMedCrossRef Barnes MP (2006) Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother 7:607–615PubMedCrossRef
36.
Zurück zum Zitat Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, Notcutt W, O’Leary C, Ratcliffe S, Novakova I, Zapletalova O, Pikova J, Ambler Z (2010) A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res 32:451–459PubMedCrossRef Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, Notcutt W, O’Leary C, Ratcliffe S, Novakova I, Zapletalova O, Pikova J, Ambler Z (2010) A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res 32:451–459PubMedCrossRef
37.
Zurück zum Zitat Mills RJ, Yap L, Young CA (2007) Treatment for ataxia in multiple sclerosis. Cochrane Database Syst Rev 1:CD005029PubMed Mills RJ, Yap L, Young CA (2007) Treatment for ataxia in multiple sclerosis. Cochrane Database Syst Rev 1:CD005029PubMed
38.
Zurück zum Zitat Timmermann L, Deuschl G, Fogel W, Hilker R, Kupsch A, Lange M, Schrader C, Sixel-Doring F, Volkmann J, Benecke R (2009) Tiefe Hirnstimulation bei Multiple-Sklerose-Tremor: Empfehlungen der Arbeitsgemeinschaft Tiefe Hirnstimulation. Nervenarzt 80:673–677PubMedCrossRef Timmermann L, Deuschl G, Fogel W, Hilker R, Kupsch A, Lange M, Schrader C, Sixel-Doring F, Volkmann J, Benecke R (2009) Tiefe Hirnstimulation bei Multiple-Sklerose-Tremor: Empfehlungen der Arbeitsgemeinschaft Tiefe Hirnstimulation. Nervenarzt 80:673–677PubMedCrossRef
39.
Zurück zum Zitat Judge SI, Bever CT Jr (2006) Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther 111:224–259PubMedCrossRef Judge SI, Bever CT Jr (2006) Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther 111:224–259PubMedCrossRef
40.
Zurück zum Zitat Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373:732–738PubMedCrossRef Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373:732–738PubMedCrossRef
41.
Zurück zum Zitat Rossini PM, Pasqualetti P, Pozzilli C, Grasso MG, Millefiorini E, Graceffa A, Carlesimo GA, Zibellini G, Caltagirone C (2001) Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler 7:354–358PubMed Rossini PM, Pasqualetti P, Pozzilli C, Grasso MG, Millefiorini E, Graceffa A, Carlesimo GA, Zibellini G, Caltagirone C (2001) Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler 7:354–358PubMed
42.
Zurück zum Zitat Kos D, Kerckhofs E, Nagels G, D’Hooghe MB, Ilsbroukx S (2008) Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 22:91–100PubMed Kos D, Kerckhofs E, Nagels G, D’Hooghe MB, Ilsbroukx S (2008) Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 22:91–100PubMed
43.
Zurück zum Zitat Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN (2002) Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 72:179–183PubMedCrossRef Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN (2002) Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 72:179–183PubMedCrossRef
44.
Zurück zum Zitat Lange R, Volkmer M, Heesen C, Liepert J (2009) Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 256:645–650PubMedCrossRef Lange R, Volkmer M, Heesen C, Liepert J (2009) Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 256:645–650PubMedCrossRef
45.
Zurück zum Zitat Brown JN, Howard CA, Kemp DW (2010) Modafinil for the treatment of multiple sclerosis-related fatigue. Ann Pharmacother 44:1098–1103PubMedCrossRef Brown JN, Howard CA, Kemp DW (2010) Modafinil for the treatment of multiple sclerosis-related fatigue. Ann Pharmacother 44:1098–1103PubMedCrossRef
46.
Zurück zum Zitat Littleton ET, Hobart JC, Palace J (2010) Modafinil for multiple sclerosis fatigue: does it work? Clin Neurol Neurosurg 112:29–31PubMedCrossRef Littleton ET, Hobart JC, Palace J (2010) Modafinil for multiple sclerosis fatigue: does it work? Clin Neurol Neurosurg 112:29–31PubMedCrossRef
47.
Zurück zum Zitat Pucci E, Branas P, D’Amico R, Giuliani G, Solari A, Taus C (2007) Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 14:CD002818 Pucci E, Branas P, D’Amico R, Giuliani G, Solari A, Taus C (2007) Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 14:CD002818
48.
Zurück zum Zitat MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, Preston TE, Cianciulli C, Krupp LB (2005) Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 64:1422–1425PubMedCrossRef MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, Preston TE, Cianciulli C, Krupp LB (2005) Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 64:1422–1425PubMedCrossRef
49.
Zurück zum Zitat Khan F, Turner-Stokes L, Stevermuer T, Simmonds F (2009) Multiple sclerosis rehabilitation outcomes: analysis of a national casemix data set from Australia. Mult Scler 15:869–875PubMedCrossRef Khan F, Turner-Stokes L, Stevermuer T, Simmonds F (2009) Multiple sclerosis rehabilitation outcomes: analysis of a national casemix data set from Australia. Mult Scler 15:869–875PubMedCrossRef
50.
Zurück zum Zitat Khan F, Pallant JF, Pallant JI, Brand C, Kilpatrick TJ (2010) A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis. J Neurol Neurosurg Psychiatry 81:1033–1038PubMedCrossRef Khan F, Pallant JF, Pallant JI, Brand C, Kilpatrick TJ (2010) A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis. J Neurol Neurosurg Psychiatry 81:1033–1038PubMedCrossRef
51.
Zurück zum Zitat Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M (2009) A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 80:470–477PubMed Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M (2009) A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 80:470–477PubMed
52.
Zurück zum Zitat Kalsi V, Gonzales G, Popat R, Apostolidis A, Elneil S, Dasgupta P, Fowler CJ (2007) Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 62:452–457PubMedCrossRef Kalsi V, Gonzales G, Popat R, Apostolidis A, Elneil S, Dasgupta P, Fowler CJ (2007) Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 62:452–457PubMedCrossRef
53.
Zurück zum Zitat Mehnert U, Birzele J, Reuter K, Schurch B (2010) The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study. J Urol 184:1011–1016PubMedCrossRef Mehnert U, Birzele J, Reuter K, Schurch B (2010) The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study. J Urol 184:1011–1016PubMedCrossRef
54.
Zurück zum Zitat Jepson RG, Mihaljevic L, Craig J (2004) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 1:CD001321PubMed Jepson RG, Mihaljevic L, Craig J (2004) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 1:CD001321PubMed
55.
Zurück zum Zitat Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG, Cazzato G (1999) Sexual dysfunction in multiple sclerosis: II. Correlation analysis. Mult Scler 5:428–431PubMed Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG, Cazzato G (1999) Sexual dysfunction in multiple sclerosis: II. Correlation analysis. Mult Scler 5:428–431PubMed
56.
Zurück zum Zitat Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New Eng J Med 338:1397–1404PubMedCrossRef Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New Eng J Med 338:1397–1404PubMedCrossRef
57.
Zurück zum Zitat DasGupta R, Fowler CJ (2003) Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs 63:153–166PubMedCrossRef DasGupta R, Fowler CJ (2003) Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs 63:153–166PubMedCrossRef
58.
Zurück zum Zitat Vidal J, Curcoll L, Roig T, Bagunya J (1995) Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients. Revista de neurologia 23:269–271PubMed Vidal J, Curcoll L, Roig T, Bagunya J (1995) Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients. Revista de neurologia 23:269–271PubMed
59.
Zurück zum Zitat Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE (2004) Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63:1579–1585PubMedCrossRef Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE (2004) Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63:1579–1585PubMedCrossRef
60.
Zurück zum Zitat Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB (2006) Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 245:127–136PubMedCrossRef Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB (2006) Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 245:127–136PubMedCrossRef
61.
Zurück zum Zitat Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J (2011) Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev 2:CD007295PubMed Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J (2011) Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev 2:CD007295PubMed
62.
Zurück zum Zitat Wade DT (1992) Measurement in neurological rehabilitation. Oxford University Press, Oxford Wade DT (1992) Measurement in neurological rehabilitation. Oxford University Press, Oxford
63.
Zurück zum Zitat Steins SA, O’Brien B, Young M (1997) The person, disablement and the process of rehabilitation. In: Steins SA, O’Brien B, Young M (eds) PM& R Secrets. Hanley & Belfus, Philidelphia, pp 1–8 Steins SA, O’Brien B, Young M (1997) The person, disablement and the process of rehabilitation. In: Steins SA, O’Brien B, Young M (eds) PM& R Secrets. Hanley & Belfus, Philidelphia, pp 1–8
64.
Zurück zum Zitat World Health Organization (WHO) (2001) International classification of functioning, disability and health (ICF). WHO, Geneva World Health Organization (WHO) (2001) International classification of functioning, disability and health (ICF). WHO, Geneva
65.
Zurück zum Zitat Khan F, Pallant JF, Zhang N, Turner-Stokes L (2010) Clinical practice improvement approach in multiple sclerosis rehabilitation: a pilot study. Int J Rehabil Res 33:238–247PubMedCrossRef Khan F, Pallant JF, Zhang N, Turner-Stokes L (2010) Clinical practice improvement approach in multiple sclerosis rehabilitation: a pilot study. Int J Rehabil Res 33:238–247PubMedCrossRef
66.
Zurück zum Zitat Khan F, Turner-Stokes L, Ng L, Kilpatrick T, Amatya B (2011) Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev 1:CD006036 Khan F, Turner-Stokes L, Ng L, Kilpatrick T, Amatya B (2011) Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev 1:CD006036
67.
Zurück zum Zitat Craig J, Young CA, Ennis M, Baker G, Boggild M (2003) A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry 74:1225–1230PubMedCrossRef Craig J, Young CA, Ennis M, Baker G, Boggild M (2003) A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry 74:1225–1230PubMedCrossRef
68.
Zurück zum Zitat Liu C, Playford ED, Thompson AJ (2003) Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J Neurol 250:1214–1218PubMedCrossRef Liu C, Playford ED, Thompson AJ (2003) Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J Neurol 250:1214–1218PubMedCrossRef
69.
Zurück zum Zitat Langdon DW, Thompson AJ (1999) Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 5:94–100PubMed Langdon DW, Thompson AJ (1999) Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 5:94–100PubMed
70.
Zurück zum Zitat Grasso MG, Troisi E, Rizzi F, Morelli D, Paolucci S (2005) Prognostic factors in multidisciplinary rehabilitation treatment in multiple sclerosis: an outcome study. Mult Scler 11:719–724PubMedCrossRef Grasso MG, Troisi E, Rizzi F, Morelli D, Paolucci S (2005) Prognostic factors in multidisciplinary rehabilitation treatment in multiple sclerosis: an outcome study. Mult Scler 11:719–724PubMedCrossRef
71.
Zurück zum Zitat Uhthoff W (1890) Untersuchungen über die bei der multiplen Herdsklerose vorkommenden Augenstörungen. Arch Psychiat Nervenkr 21:303–410 Uhthoff W (1890) Untersuchungen über die bei der multiplen Herdsklerose vorkommenden Augenstörungen. Arch Psychiat Nervenkr 21:303–410
72.
Zurück zum Zitat Smith KJ, McDonald WI (1999) The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 354:1649–1673PubMedCrossRef Smith KJ, McDonald WI (1999) The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 354:1649–1673PubMedCrossRef
73.
Zurück zum Zitat Humm AM, Beer S, Kool J, Magistris MR, Kesselring J, Rosler KM (2004) Quantification of Uhthoff’s phenomenon in multiple sclerosis: a magnetic stimulation study. Clin Neurophysiol (Official Journal of the International Federation of Clinical Neurophysiology) 115:2493–2501CrossRef Humm AM, Beer S, Kool J, Magistris MR, Kesselring J, Rosler KM (2004) Quantification of Uhthoff’s phenomenon in multiple sclerosis: a magnetic stimulation study. Clin Neurophysiol (Official Journal of the International Federation of Clinical Neurophysiology) 115:2493–2501CrossRef
74.
Zurück zum Zitat Sheean GL, Murray NMF, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120:299–315PubMedCrossRef Sheean GL, Murray NMF, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120:299–315PubMedCrossRef
75.
Zurück zum Zitat Dalgas U, Stenager E, Ingemann-Hansen T (2008) Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training. Mult Scler 14:35–53PubMedCrossRef Dalgas U, Stenager E, Ingemann-Hansen T (2008) Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training. Mult Scler 14:35–53PubMedCrossRef
76.
Zurück zum Zitat Smith RM, Adeney-Steel M, Fulcher G, Longley WA (2006) Symptom change with exercise is a temporary phenomenon for people with multiple sclerosis. Arch Phys Med Rehabil 87:723–727PubMedCrossRef Smith RM, Adeney-Steel M, Fulcher G, Longley WA (2006) Symptom change with exercise is a temporary phenomenon for people with multiple sclerosis. Arch Phys Med Rehabil 87:723–727PubMedCrossRef
77.
Zurück zum Zitat Bjarnadottir OH, Konradsdottir AD, Reynisdottir K, Olafsson E (2007) Multiple sclerosis and brief moderate exercise: a randomised study. Mult Scler 13:776–782PubMedCrossRef Bjarnadottir OH, Konradsdottir AD, Reynisdottir K, Olafsson E (2007) Multiple sclerosis and brief moderate exercise: a randomised study. Mult Scler 13:776–782PubMedCrossRef
78.
Zurück zum Zitat Rocca MA, Falini A, Colombo B, Scotti G, Comi G, Filippi M (2002) Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 51:330–339PubMedCrossRef Rocca MA, Falini A, Colombo B, Scotti G, Comi G, Filippi M (2002) Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 51:330–339PubMedCrossRef
79.
Zurück zum Zitat Cifelli A, Matthews PM (2002) Cerebral plasticity in multiple sclerosis: insights from fMRI. Mult Scler 8:193–199PubMedCrossRef Cifelli A, Matthews PM (2002) Cerebral plasticity in multiple sclerosis: insights from fMRI. Mult Scler 8:193–199PubMedCrossRef
80.
Zurück zum Zitat Thickbroom GW, Sacco P, Faulkner DL, Kermode AG, Mastaglia FL (2008) Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis. J Neurol 255:1001–1005PubMedCrossRef Thickbroom GW, Sacco P, Faulkner DL, Kermode AG, Mastaglia FL (2008) Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis. J Neurol 255:1001–1005PubMedCrossRef
81.
Zurück zum Zitat Penner IK, Opwis K, Kappos L (2007) Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. J Neurol 254(Suppl 2):II53–II57PubMedCrossRef Penner IK, Opwis K, Kappos L (2007) Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. J Neurol 254(Suppl 2):II53–II57PubMedCrossRef
82.
Zurück zum Zitat Heesen C, Romberg A, Gold S, Schulz KH (2006) Physical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatment. Expert Rev Neurother 6:347–355PubMedCrossRef Heesen C, Romberg A, Gold S, Schulz KH (2006) Physical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatment. Expert Rev Neurother 6:347–355PubMedCrossRef
83.
Zurück zum Zitat Freeman JA, Langdon DW, Hobart JC, Thompson AJ (1999) Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 52:50–56PubMedCrossRef Freeman JA, Langdon DW, Hobart JC, Thompson AJ (1999) Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 52:50–56PubMedCrossRef
84.
Zurück zum Zitat World Health Organization (WHO) (2004) Comunity based rehabilitation: a strategy for rehabilitation, equalization of opportunities, poverty reduction and social Inclusion of people with disabilities. WHO Library Joint Position Paper 2004 World Health Organization (WHO) (2004) Comunity based rehabilitation: a strategy for rehabilitation, equalization of opportunities, poverty reduction and social Inclusion of people with disabilities. WHO Library Joint Position Paper 2004
85.
Zurück zum Zitat Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability rating scale (EDSS). Neurology 13:1444–1452CrossRef Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability rating scale (EDSS). Neurology 13:1444–1452CrossRef
86.
Zurück zum Zitat Twork S, Wiesmeth S, Spindler M, Wirtz M, Schipper S, Pohlau D, Klewer J, Kugler J (2010) Disability status and quality of life in multiple sclerosis: non-linearity of the expanded disability status scale (EDSS). Health Qual Life Outcomes 8:55PubMedCrossRef Twork S, Wiesmeth S, Spindler M, Wirtz M, Schipper S, Pohlau D, Klewer J, Kugler J (2010) Disability status and quality of life in multiple sclerosis: non-linearity of the expanded disability status scale (EDSS). Health Qual Life Outcomes 8:55PubMedCrossRef
87.
Zurück zum Zitat van Winsen LM, Kragt JJ, Hoogervorst EL, Polman CH, Uitdehaag BM (2010) Outcome measurement in multiple sclerosis: detection of clinically relevant improvement. Mult Scler 16:604–610PubMedCrossRef van Winsen LM, Kragt JJ, Hoogervorst EL, Polman CH, Uitdehaag BM (2010) Outcome measurement in multiple sclerosis: detection of clinically relevant improvement. Mult Scler 16:604–610PubMedCrossRef
88.
Zurück zum Zitat Cadavid D, Tang Y, O’Neill G (2010) Responsiveness of the expanded disability status scale (EDSS) to disease progression and therapeutic intervention in progressive forms of multiple sclerosis. Revista de neurologia 51:321–329PubMed Cadavid D, Tang Y, O’Neill G (2010) Responsiveness of the expanded disability status scale (EDSS) to disease progression and therapeutic intervention in progressive forms of multiple sclerosis. Revista de neurologia 51:321–329PubMed
89.
Zurück zum Zitat Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ (2004) Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 8(iii):1–48 Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ (2004) Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 8(iii):1–48
90.
Zurück zum Zitat Kesselring J, Coenen M, Cieza A, Thompson A, Kostanjsek N, Stucki G (2008) Developing the ICF Core Sets for multiple sclerosis to specify functioning. Mult Scler 14:252–254PubMedCrossRef Kesselring J, Coenen M, Cieza A, Thompson A, Kostanjsek N, Stucki G (2008) Developing the ICF Core Sets for multiple sclerosis to specify functioning. Mult Scler 14:252–254PubMedCrossRef
91.
Zurück zum Zitat Coenen M, Cieza A, Freeman J, Khan F, Miller D, Weise A, Kesselring J (2011) The development of ICF Core Sets for multiple sclerosis: results of the international consensus conference. J Neurol 258:1477–1488PubMedCrossRef Coenen M, Cieza A, Freeman J, Khan F, Miller D, Weise A, Kesselring J (2011) The development of ICF Core Sets for multiple sclerosis: results of the international consensus conference. J Neurol 258:1477–1488PubMedCrossRef
92.
Zurück zum Zitat National Institute for Clinical Excellence (NICE) (2003) Management of multiple sclerosis in primary and secondary care. Clinical guidelines 8. NICE, London National Institute for Clinical Excellence (NICE) (2003) Management of multiple sclerosis in primary and secondary care. Clinical guidelines 8. NICE, London
93.
Zurück zum Zitat Department of Health (2005) The national service framework (NSF) for long-term conditions. Department of Health, London Department of Health (2005) The national service framework (NSF) for long-term conditions. Department of Health, London
94.
Zurück zum Zitat Motl RW, McAuley E, Snook EM (2005) Physical activity and multiple sclerosis: a meta-analysis. Mult Scler 11:459–463PubMedCrossRef Motl RW, McAuley E, Snook EM (2005) Physical activity and multiple sclerosis: a meta-analysis. Mult Scler 11:459–463PubMedCrossRef
95.
Zurück zum Zitat Motl RW, Snook EM, McAuley E, Scott JA, Hinkle ML (2007) Demographic correlates of physical activity in individuals with multiple sclerosis. Disabil Rehabil 29:1301–1304PubMedCrossRef Motl RW, Snook EM, McAuley E, Scott JA, Hinkle ML (2007) Demographic correlates of physical activity in individuals with multiple sclerosis. Disabil Rehabil 29:1301–1304PubMedCrossRef
96.
Zurück zum Zitat Doerksen SE, Motl RW, McAuley E (2007) Environmental correlates of physical activity in multiple sclerosis: a cross-sectional study. Int J Behav Nutr Phys Act 4:49PubMedCrossRef Doerksen SE, Motl RW, McAuley E (2007) Environmental correlates of physical activity in multiple sclerosis: a cross-sectional study. Int J Behav Nutr Phys Act 4:49PubMedCrossRef
97.
Zurück zum Zitat National Health and Medical Research Council (NHMRC) (2009) NHMRC levels of evidence and grades for recommendations for developers of guidelines. In: NHMRC National Health and Medical Research Council (NHMRC) (2009) NHMRC levels of evidence and grades for recommendations for developers of guidelines. In: NHMRC
98.
Zurück zum Zitat Stuifbergen AK, Blozis SA, Harrison TC, Becker HA (2006) Exercise, functional limitations, and quality of life: a longitudinal study of persons with multiple sclerosis. Arch Phys Med Rehabil 87:935–943PubMedCrossRef Stuifbergen AK, Blozis SA, Harrison TC, Becker HA (2006) Exercise, functional limitations, and quality of life: a longitudinal study of persons with multiple sclerosis. Arch Phys Med Rehabil 87:935–943PubMedCrossRef
99.
Zurück zum Zitat Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G (2011) Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev:CD003980 Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G (2011) Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev:CD003980
100.
Zurück zum Zitat Snook EM, Motl RW (2009) Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabilitation Neural Repair 23:108–116PubMedCrossRef Snook EM, Motl RW (2009) Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabilitation Neural Repair 23:108–116PubMedCrossRef
101.
Zurück zum Zitat Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, Overgaard K, Ingemann-Hansen T (2009) Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 73:1478–1484PubMedCrossRef Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, Overgaard K, Ingemann-Hansen T (2009) Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 73:1478–1484PubMedCrossRef
102.
Zurück zum Zitat Dalgas U, Stenager E, Jakobsen J, Petersen T, Overgaard K, Ingemann-Hansen T (2010) Muscle fiber size increases following resistance training in multiple sclerosis. Mult Scler 16:1367–1376PubMedCrossRef Dalgas U, Stenager E, Jakobsen J, Petersen T, Overgaard K, Ingemann-Hansen T (2010) Muscle fiber size increases following resistance training in multiple sclerosis. Mult Scler 16:1367–1376PubMedCrossRef
103.
Zurück zum Zitat Rasova K, Havrdova E, Brandejsky P, Zalisova M, Foubikova B, Martinkova P (2006) Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. Mult Scler 12:227–234PubMedCrossRef Rasova K, Havrdova E, Brandejsky P, Zalisova M, Foubikova B, Martinkova P (2006) Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. Mult Scler 12:227–234PubMedCrossRef
104.
Zurück zum Zitat McAuley E, Motl RW, Morris KS, Hu L, Doerksen SE, Elavsky S, Konopack JF (2007) Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial. Mult Scler 13:652–659PubMedCrossRef McAuley E, Motl RW, Morris KS, Hu L, Doerksen SE, Elavsky S, Konopack JF (2007) Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial. Mult Scler 13:652–659PubMedCrossRef
105.
Zurück zum Zitat van den Berg M, Dawes H, Wade DT, Newman M, Burridge J, Izadi H, Sackley CM (2006) Treadmill training for individuals with multiple sclerosis: a pilot randomised trial. J Neurol Neurosurg Psychiatry 77:531–533PubMedCrossRef van den Berg M, Dawes H, Wade DT, Newman M, Burridge J, Izadi H, Sackley CM (2006) Treadmill training for individuals with multiple sclerosis: a pilot randomised trial. J Neurol Neurosurg Psychiatry 77:531–533PubMedCrossRef
106.
Zurück zum Zitat Giesser B, Beres-Jones J, Budovitch A, Herlihy E, Harkema S (2007) Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. Mult Scler 13:224–231PubMedCrossRef Giesser B, Beres-Jones J, Budovitch A, Herlihy E, Harkema S (2007) Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. Mult Scler 13:224–231PubMedCrossRef
107.
Zurück zum Zitat Newman MA, Dawes H, van den Berg M, Wade DT, Burridge J, Izadi H (2007) Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study. Mult Scler 13:113–119PubMedCrossRef Newman MA, Dawes H, van den Berg M, Wade DT, Burridge J, Izadi H (2007) Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study. Mult Scler 13:113–119PubMedCrossRef
108.
Zurück zum Zitat Pilutti LA, Lelli DA, Paulseth JE, Crome M, Jiang S, Rathbone MP, Hicks AL (2011) Effects of 12 weeks of supported treadmill training on functional ability and quality of life in progressive multiple sclerosis: a pilot study. Arch Phys Med Rehabil 92:31–36PubMedCrossRef Pilutti LA, Lelli DA, Paulseth JE, Crome M, Jiang S, Rathbone MP, Hicks AL (2011) Effects of 12 weeks of supported treadmill training on functional ability and quality of life in progressive multiple sclerosis: a pilot study. Arch Phys Med Rehabil 92:31–36PubMedCrossRef
109.
Zurück zum Zitat Beer S, Aschbacher B, Manoglou D, Gamper E, Kool J, Kesselring J (2008) Robot-assisted gait training in multiple sclerosis: a pilot randomized trial. Mult Scler 14:231–236PubMedCrossRef Beer S, Aschbacher B, Manoglou D, Gamper E, Kool J, Kesselring J (2008) Robot-assisted gait training in multiple sclerosis: a pilot randomized trial. Mult Scler 14:231–236PubMedCrossRef
110.
Zurück zum Zitat Schwartz I, Sajin A, Moreh E, Fisher I, Neeb M, Forest A, Vaknin-Dembinsky A, Karussis D, Meiner Z (2011) Robot-assisted gait training in multiple sclerosis patients: a randomized trial. Mult Scler [Epub ahead of print] Schwartz I, Sajin A, Moreh E, Fisher I, Neeb M, Forest A, Vaknin-Dembinsky A, Karussis D, Meiner Z (2011) Robot-assisted gait training in multiple sclerosis patients: a randomized trial. Mult Scler [Epub ahead of print]
111.
Zurück zum Zitat Künzle U (2000) Schweizer Studie über die Wirksamkeit der Hippotherapie-K bei Multiple-Sklerose-Patienten: Hippotherapie. Springer, Berlin Heidelberg New York, pp 359–381 Künzle U (2000) Schweizer Studie über die Wirksamkeit der Hippotherapie-K bei Multiple-Sklerose-Patienten: Hippotherapie. Springer, Berlin Heidelberg New York, pp 359–381
112.
Zurück zum Zitat Bronson C, Brewerton K, Ong J, Palanca C, Sullivan SJ (2010) Does hippotherapy improve balance in persons with multiple sclerosis: a systematic review. Eur J Phys Rehabil Med 46:347–353PubMed Bronson C, Brewerton K, Ong J, Palanca C, Sullivan SJ (2010) Does hippotherapy improve balance in persons with multiple sclerosis: a systematic review. Eur J Phys Rehabil Med 46:347–353PubMed
113.
Zurück zum Zitat Silkwood-Sherer D, Warmbier H (2007) Effects of hippotherapy on postural stability, in persons with multiple sclerosis: a pilot study. J Neurol Phys Ther 31:77–84PubMed Silkwood-Sherer D, Warmbier H (2007) Effects of hippotherapy on postural stability, in persons with multiple sclerosis: a pilot study. J Neurol Phys Ther 31:77–84PubMed
114.
Zurück zum Zitat Gamper UN (1995) Wasserspezifische Bewegungstherapie und Training. Gustav Fischer Verlag, Stuttgart Gamper UN (1995) Wasserspezifische Bewegungstherapie und Training. Gustav Fischer Verlag, Stuttgart
115.
Zurück zum Zitat Kesiktas N, Paker N, Erdogan N, Gulsen G, Bicki D, Yilmaz H (2004) The use of hydrotherapy for the management of spasticity. Neurorehabilitation Neural Repair 18:268–273PubMedCrossRef Kesiktas N, Paker N, Erdogan N, Gulsen G, Bicki D, Yilmaz H (2004) The use of hydrotherapy for the management of spasticity. Neurorehabilitation Neural Repair 18:268–273PubMedCrossRef
116.
Zurück zum Zitat Salem Y, Scott AH, Karpatkin H, Concert G, Haller L, Kaminsky E, Weisbrot R, Spatz E (2011) Community-based group aquatic programme for individuals with multiple sclerosis: a pilot study. Disabil Rehabil 33:720–728PubMedCrossRef Salem Y, Scott AH, Karpatkin H, Concert G, Haller L, Kaminsky E, Weisbrot R, Spatz E (2011) Community-based group aquatic programme for individuals with multiple sclerosis: a pilot study. Disabil Rehabil 33:720–728PubMedCrossRef
117.
Zurück zum Zitat Castro-Sánchez AM, Matarán-Peñarrocha GA, Lara-Palomo I, Saavedra-Hernández M, Arroyo-Morales M, Moreno-Lorenzo C (2012) Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evid Based Complement Alternat Med [Epub ahead of print] Castro-Sánchez AM, Matarán-Peñarrocha GA, Lara-Palomo I, Saavedra-Hernández M, Arroyo-Morales M, Moreno-Lorenzo C (2012) Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evid Based Complement Alternat Med [Epub ahead of print]
118.
Zurück zum Zitat Beenakker EA, Oparina TI, Hartgring A, Teelken A, Arutjunyan AV, De Keyser J (2001) Cooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production. Neurology 57:892–894PubMedCrossRef Beenakker EA, Oparina TI, Hartgring A, Teelken A, Arutjunyan AV, De Keyser J (2001) Cooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production. Neurology 57:892–894PubMedCrossRef
119.
Zurück zum Zitat White AT, Wilson TE, Davis SL, Petajan JH (2000) Effect of precooling on physical performance in multiple sclerosis. Mult Scler 6:176–180PubMed White AT, Wilson TE, Davis SL, Petajan JH (2000) Effect of precooling on physical performance in multiple sclerosis. Mult Scler 6:176–180PubMed
120.
Zurück zum Zitat Warke K, Al-Smadi J, Baxter D, Walsh DM, Lowe-Strong AS (2006) Efficacy of transcutaneous electrical nerve stimulation (tens) for chronic low-back pain in a multiple sclerosis population: a randomized, placebo-controlled clinical trial. Clin J Pain 22:812–819PubMedCrossRef Warke K, Al-Smadi J, Baxter D, Walsh DM, Lowe-Strong AS (2006) Efficacy of transcutaneous electrical nerve stimulation (tens) for chronic low-back pain in a multiple sclerosis population: a randomized, placebo-controlled clinical trial. Clin J Pain 22:812–819PubMedCrossRef
121.
Zurück zum Zitat Al-Smadi J, Warke K, Wilson I, Cramp AF, Noble G, Walsh DM, Lowe-Strong AS (2003) A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis. Clin Rehabil 17:742–749PubMedCrossRef Al-Smadi J, Warke K, Wilson I, Cramp AF, Noble G, Walsh DM, Lowe-Strong AS (2003) A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis. Clin Rehabil 17:742–749PubMedCrossRef
122.
Zurück zum Zitat Steultjens EM, Dekker J, Bouter LM, Cardol M, Van de Nes JC, Van den Ende CH (2009) Occupational therapy for multiple sclerosis. Cochrane Database Syst Rev 1:CD003608 Steultjens EM, Dekker J, Bouter LM, Cardol M, Van de Nes JC, Van den Ende CH (2009) Occupational therapy for multiple sclerosis. Cochrane Database Syst Rev 1:CD003608
123.
Zurück zum Zitat Baker NA, Tickle-Degnen L (2001) The effectiveness of physical, psychological, and functional interventions in treating clients with multiple sclerosis: a meta-analysis. Am J Occup Ther 55:324–331PubMedCrossRef Baker NA, Tickle-Degnen L (2001) The effectiveness of physical, psychological, and functional interventions in treating clients with multiple sclerosis: a meta-analysis. Am J Occup Ther 55:324–331PubMedCrossRef
124.
Zurück zum Zitat Souza A, Kelleher A, Cooper R, Cooper RA, Iezzoni LI, Collins DM (2010) Multiple sclerosis and mobility-related assistive technology: systematic review of literature. J Rehabil Res Dev 47:213–223PubMedCrossRef Souza A, Kelleher A, Cooper R, Cooper RA, Iezzoni LI, Collins DM (2010) Multiple sclerosis and mobility-related assistive technology: systematic review of literature. J Rehabil Res Dev 47:213–223PubMedCrossRef
125.
Zurück zum Zitat Bartholome G (1999) Schluckstörungen. In: Frommelt P, Grötzbach H (eds) Neurorehabilitation. Blackwell Wissenschafts-Verlag, Berlin Wien, pp 107–124 Bartholome G (1999) Schluckstörungen. In: Frommelt P, Grötzbach H (eds) Neurorehabilitation. Blackwell Wissenschafts-Verlag, Berlin Wien, pp 107–124
126.
Zurück zum Zitat Prosiegel M, Heintze M, Wagner-Sonntag E, Hannig C, Wuttge-Hannig A, Yassouridis A (2002) Schluckstörungen bei neurologischen Patienten: Eine prospektive Studie zu Diagnostik, Störungsmustern, Therapie und Outcome. Nervenarzt 73:364–370PubMedCrossRef Prosiegel M, Heintze M, Wagner-Sonntag E, Hannig C, Wuttge-Hannig A, Yassouridis A (2002) Schluckstörungen bei neurologischen Patienten: Eine prospektive Studie zu Diagnostik, Störungsmustern, Therapie und Outcome. Nervenarzt 73:364–370PubMedCrossRef
127.
Zurück zum Zitat Gosselink R, Kovacs L, Ketelaer P, Carton H, Decramer M (2000) Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil 81:747–751PubMed Gosselink R, Kovacs L, Ketelaer P, Carton H, Decramer M (2000) Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil 81:747–751PubMed
128.
Zurück zum Zitat Chiara T, Martin D, Sapienza C (2007) Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis. Neurorehabilitation Neural Repair 21:239–249PubMedCrossRef Chiara T, Martin D, Sapienza C (2007) Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis. Neurorehabilitation Neural Repair 21:239–249PubMedCrossRef
129.
Zurück zum Zitat Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139–1151PubMedCrossRef Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139–1151PubMedCrossRef
130.
Zurück zum Zitat Rosti-Otajarvi EM, Hamalainen PI (2011) Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev 11:CD009131PubMed Rosti-Otajarvi EM, Hamalainen PI (2011) Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev 11:CD009131PubMed
131.
Zurück zum Zitat Thomas PW, Thomas S, Hillier C, Galvin K, Baker R (2009) Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 1:CD004431 Thomas PW, Thomas S, Hillier C, Galvin K, Baker R (2009) Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 1:CD004431
132.
Zurück zum Zitat Forman AC, Lincoln NB (2010) Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil 24:211–221PubMedCrossRef Forman AC, Lincoln NB (2010) Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil 24:211–221PubMedCrossRef
133.
Zurück zum Zitat O’Brien AR, Chiaravalloti N, Goverover Y, Deluca J (2008) Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil 89:761–769PubMedCrossRef O’Brien AR, Chiaravalloti N, Goverover Y, Deluca J (2008) Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil 89:761–769PubMedCrossRef
134.
Zurück zum Zitat Mattioli F, Stampatori C, Bellomi F, Capra R, Rocca M, Filippi M (2010) Neuropsychological rehabilitation in adult multiple sclerosis. Neurol Sci 31:S271–S274PubMedCrossRef Mattioli F, Stampatori C, Bellomi F, Capra R, Rocca M, Filippi M (2010) Neuropsychological rehabilitation in adult multiple sclerosis. Neurol Sci 31:S271–S274PubMedCrossRef
135.
Zurück zum Zitat Benedict RH, Shapiro A, Priore R, Miller C, Munschauer F, Jacobs L (2000) Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Mult Scler 6:391–396PubMed Benedict RH, Shapiro A, Priore R, Miller C, Munschauer F, Jacobs L (2000) Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Mult Scler 6:391–396PubMed
136.
Zurück zum Zitat Lincoln NB, Dent A, Harding J, Weyman N, Nicholl C, Blumhardt LD, Playford ED (2002) Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 72:93–98PubMedCrossRef Lincoln NB, Dent A, Harding J, Weyman N, Nicholl C, Blumhardt LD, Playford ED (2002) Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 72:93–98PubMedCrossRef
137.
Zurück zum Zitat Cosio D, Jin L, Siddique J, Mohr DC (2011) The effect of telephone-administered cognitive-behavioral therapy on quality of life among patients with multiple sclerosis. Ann Behav Med 41:227–234PubMedCrossRef Cosio D, Jin L, Siddique J, Mohr DC (2011) The effect of telephone-administered cognitive-behavioral therapy on quality of life among patients with multiple sclerosis. Ann Behav Med 41:227–234PubMedCrossRef
138.
Zurück zum Zitat van Kessel K, Moss-Morris R, Willoughby E, Chalder T, Johnson MH, Robinson E (2008) A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom Med 70:205–213PubMedCrossRef van Kessel K, Moss-Morris R, Willoughby E, Chalder T, Johnson MH, Robinson E (2008) A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom Med 70:205–213PubMedCrossRef
139.
Zurück zum Zitat Khan F, Ng L, Turner-Stokes L (2011) Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis. Cochrane Database Syst Rev 1:CD007256 Khan F, Ng L, Turner-Stokes L (2011) Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis. Cochrane Database Syst Rev 1:CD007256
140.
Zurück zum Zitat Pantano P, Mainero C, Caramia F (2006) Functional brain reorganization in multiple sclerosis: evidence from fMRI studies. J Neuroimaging 16:104–114PubMedCrossRef Pantano P, Mainero C, Caramia F (2006) Functional brain reorganization in multiple sclerosis: evidence from fMRI studies. J Neuroimaging 16:104–114PubMedCrossRef
141.
Zurück zum Zitat Finkelstein J, Wood J (2009) Design and implementation of Home Automated Telemanagement system for patients with multiple sclerosis. Conf Proc IEEE Eng Med Biol Soc 2009:6091–6094PubMed Finkelstein J, Wood J (2009) Design and implementation of Home Automated Telemanagement system for patients with multiple sclerosis. Conf Proc IEEE Eng Med Biol Soc 2009:6091–6094PubMed
142.
Zurück zum Zitat Mori F, Ljoka C, Magni E, Codeca C, Kusayanagi H, Monteleone F, Sancesario A, Bernardi G, Koch G, Foti C, Centonze D (2011) Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. J Neurol 258(7):1281–1287PubMedCrossRef Mori F, Ljoka C, Magni E, Codeca C, Kusayanagi H, Monteleone F, Sancesario A, Bernardi G, Koch G, Foti C, Centonze D (2011) Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. J Neurol 258(7):1281–1287PubMedCrossRef
143.
Zurück zum Zitat Judica E, Martinelli Boneschi F, Ungaro D, Comola M, Gatti R, Comi G, Rossi P (2011) Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis. J Neurol 258:835–839PubMedCrossRef Judica E, Martinelli Boneschi F, Ungaro D, Comola M, Gatti R, Comi G, Rossi P (2011) Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis. J Neurol 258:835–839PubMedCrossRef
144.
Zurück zum Zitat Sacco R, Bussman R, Oesch P, Kesselring J, Beer S (2011) Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial. J Neurol 258:889–894PubMedCrossRef Sacco R, Bussman R, Oesch P, Kesselring J, Beer S (2011) Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial. J Neurol 258:889–894PubMedCrossRef
145.
Zurück zum Zitat Di Fabio RP, Soderberg J, Choi T, Hansen CR, Schapiro RT (1998) Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 79:141–146PubMedCrossRef Di Fabio RP, Soderberg J, Choi T, Hansen CR, Schapiro RT (1998) Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 79:141–146PubMedCrossRef
146.
Zurück zum Zitat Brañas P, Jordan R, Fry-Smith A, Burls A, Hyde C (2000) Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 4:1–61PubMed Brañas P, Jordan R, Fry-Smith A, Burls A, Hyde C (2000) Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 4:1–61PubMed
147.
Zurück zum Zitat Andreasen AK, Stenager E, Dalgas U (2011) The effect of exercise therapy on fatigue in multiple sclerosis. Mult Scler 17:1041–1054PubMedCrossRef Andreasen AK, Stenager E, Dalgas U (2011) The effect of exercise therapy on fatigue in multiple sclerosis. Mult Scler 17:1041–1054PubMedCrossRef
148.
Zurück zum Zitat Neill J, Belan I, Ried K (2006) Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs 56:617–635PubMedCrossRef Neill J, Belan I, Ried K (2006) Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs 56:617–635PubMedCrossRef
149.
Zurück zum Zitat Huntley A, Ernst E (2000) Complementary and alternative therapies for treating multiple sclerosis symptoms: a systematic review. Complement Ther Med 8:97–105PubMedCrossRef Huntley A, Ernst E (2000) Complementary and alternative therapies for treating multiple sclerosis symptoms: a systematic review. Complement Ther Med 8:97–105PubMedCrossRef
150.
Zurück zum Zitat de Carvalho ML, Motta R, Konrad G, Battaglia MA, Brichetto G (2012) A randomized placebo-controlled cross-over study using a low-frequency magnetic field in the treatment of fatigue in multiple sclerosis. Mult Scler 18:82–89PubMedCrossRef de Carvalho ML, Motta R, Konrad G, Battaglia MA, Brichetto G (2012) A randomized placebo-controlled cross-over study using a low-frequency magnetic field in the treatment of fatigue in multiple sclerosis. Mult Scler 18:82–89PubMedCrossRef
151.
Zurück zum Zitat Bovend’Eerdt TJ, Minelli C, Newman M et al (2008) The effects of stretching in spasticity: a systematic review. Arch Phys Med Rehabil 89:1395–1406PubMedCrossRef Bovend’Eerdt TJ, Minelli C, Newman M et al (2008) The effects of stretching in spasticity: a systematic review. Arch Phys Med Rehabil 89:1395–1406PubMedCrossRef
152.
Zurück zum Zitat Vahtera T, Haaranen M, Viramo-Koskela AL, Ruutiainen J (1997) Pelvic floor rehabilitation is effective in patients with multiple sclerosis. Clin Rehabil 11:211–219PubMedCrossRef Vahtera T, Haaranen M, Viramo-Koskela AL, Ruutiainen J (1997) Pelvic floor rehabilitation is effective in patients with multiple sclerosis. Clin Rehabil 11:211–219PubMedCrossRef
153.
Zurück zum Zitat Lúcio AC, Perissinoto MC, Natalin RA, Prudente A, Damasceno BP, D’ancona CA (2011) A comparative study of pelvic floor muscle training in women with multiple sclerosis: its impact on lower urinary tract symptoms and quality of life. Clinics (Sao Paulo) 66:1563–1568CrossRef Lúcio AC, Perissinoto MC, Natalin RA, Prudente A, Damasceno BP, D’ancona CA (2011) A comparative study of pelvic floor muscle training in women with multiple sclerosis: its impact on lower urinary tract symptoms and quality of life. Clinics (Sao Paulo) 66:1563–1568CrossRef
154.
Zurück zum Zitat DasGupta P, Haslam C, Goodwin R, Fowler CJ (1997) The ‘Queen Square bladder stimulator’: a device for assisting emptying of the neurogenic bladder. Br J Urol 80:234–237PubMedCrossRef DasGupta P, Haslam C, Goodwin R, Fowler CJ (1997) The ‘Queen Square bladder stimulator’: a device for assisting emptying of the neurogenic bladder. Br J Urol 80:234–237PubMedCrossRef
155.
Zurück zum Zitat Prasad RS, Smith SJ, Wright H (2003) Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study. Clin Rehabil 17:42–47PubMedCrossRef Prasad RS, Smith SJ, Wright H (2003) Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study. Clin Rehabil 17:42–47PubMedCrossRef
156.
Zurück zum Zitat Blackmore DE, Hart SL, Albiani JJ, Mohr DC (2011) Improvements in partner support predict sexual satisfaction among individuals with multiple sclerosis. Rehabil Psychol 56:117–122PubMedCrossRef Blackmore DE, Hart SL, Albiani JJ, Mohr DC (2011) Improvements in partner support predict sexual satisfaction among individuals with multiple sclerosis. Rehabil Psychol 56:117–122PubMedCrossRef
157.
Zurück zum Zitat Fletcher SG, Castro-Borrero W, Remington G, Treadaway K, Lemack GE, Frohman EM (2009) Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 6:96–107PubMedCrossRef Fletcher SG, Castro-Borrero W, Remington G, Treadaway K, Lemack GE, Frohman EM (2009) Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 6:96–107PubMedCrossRef
158.
Zurück zum Zitat Wiles CM (2008) Physiotherapy and related activities in multiple sclerosis. Mult Scler 14:863–871PubMedCrossRef Wiles CM (2008) Physiotherapy and related activities in multiple sclerosis. Mult Scler 14:863–871PubMedCrossRef
159.
Zurück zum Zitat Sabapathy NM, Minahan CL, Turner GT, Broadley SA (2011) Comparing endurance- and resistance-exercise training in people with multiple sclerosis: a randomized pilot study. Clin Rehabil 25:14–24PubMedCrossRef Sabapathy NM, Minahan CL, Turner GT, Broadley SA (2011) Comparing endurance- and resistance-exercise training in people with multiple sclerosis: a randomized pilot study. Clin Rehabil 25:14–24PubMedCrossRef
160.
Zurück zum Zitat Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:432–441PubMedCrossRef Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:432–441PubMedCrossRef
161.
Zurück zum Zitat Mostert S, Kesselring J (2002) Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 8:161–168PubMedCrossRef Mostert S, Kesselring J (2002) Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 8:161–168PubMedCrossRef
162.
Zurück zum Zitat Kileff J, Ashburn A (2005) A pilot study of the effect of aerobic exercise on people with moderate disability multiple sclerosis. Clin Rehabil 19:165–169PubMedCrossRef Kileff J, Ashburn A (2005) A pilot study of the effect of aerobic exercise on people with moderate disability multiple sclerosis. Clin Rehabil 19:165–169PubMedCrossRef
163.
Zurück zum Zitat Rampello A, Franceschini M, Piepoli M, Antenucci R, Lenti G, Olivieri D, Chetta A (2007) Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Phys Ther 87:545–555, discussion 555-549PubMedCrossRef Rampello A, Franceschini M, Piepoli M, Antenucci R, Lenti G, Olivieri D, Chetta A (2007) Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Phys Ther 87:545–555, discussion 555-549PubMedCrossRef
164.
Zurück zum Zitat Lo AC, Triche EW (2008) Improving gait in multiple sclerosis using robot-assisted, body weight supported treadmill training. Neurorehabilitation Neural Repair 22:661–671PubMedCrossRef Lo AC, Triche EW (2008) Improving gait in multiple sclerosis using robot-assisted, body weight supported treadmill training. Neurorehabilitation Neural Repair 22:661–671PubMedCrossRef
165.
Zurück zum Zitat Wier LM, Hatcher MS, Triche EW, Lo AC (2011) Effect of robot-assisted versus conventional body-weight-supported treadmill training on quality of life for people with multiple sclerosis. J Rehabil Res Dev 48:483–492PubMedCrossRef Wier LM, Hatcher MS, Triche EW, Lo AC (2011) Effect of robot-assisted versus conventional body-weight-supported treadmill training on quality of life for people with multiple sclerosis. J Rehabil Res Dev 48:483–492PubMedCrossRef
166.
Zurück zum Zitat Nilsagard Y, Denison E, Gunnarsson LG (2006) Evaluation of a single session with cooling garment for persons with multiple sclerosis–a randomized trial. Disabil Rehabil Assist Technol 1:225–233PubMedCrossRef Nilsagard Y, Denison E, Gunnarsson LG (2006) Evaluation of a single session with cooling garment for persons with multiple sclerosis–a randomized trial. Disabil Rehabil Assist Technol 1:225–233PubMedCrossRef
167.
Zurück zum Zitat Meyer-Heim A, Rothmaier M, Weder M, Kool J, Schenk P, Kesselring J (2007) Advanced lightweight cooling-garment technology: functional improvements in thermosensitive patients with multiple sclerosis. Mult Scler 13:232–237PubMedCrossRef Meyer-Heim A, Rothmaier M, Weder M, Kool J, Schenk P, Kesselring J (2007) Advanced lightweight cooling-garment technology: functional improvements in thermosensitive patients with multiple sclerosis. Mult Scler 13:232–237PubMedCrossRef
168.
Zurück zum Zitat Fowler CJ (2010) The effectiveness of bladder rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 81:944PubMedCrossRef Fowler CJ (2010) The effectiveness of bladder rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 81:944PubMedCrossRef
169.
Zurück zum Zitat Miller L, Mattison P, Wood P, Wood L (2007) The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis. Mult Scler 13:527–533 Miller L, Mattison P, Wood P, Wood L (2007) The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis. Mult Scler 13:527–533
Metadaten
Titel
Rehabilitation interventions in multiple sclerosis: an overview
verfasst von
Serafin Beer
Fary Khan
Jürg Kesselring
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6577-4

Weitere Artikel der Ausgabe 9/2012

Journal of Neurology 9/2012 Zur Ausgabe

Journal Club

Neuroimaging

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.